Marker Therapeutics Income Statement (2015-2025) | MRKR

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Revenue & cost
Revenue (Quarter)					0.96M	0.79M	1.00M	0.76M	2.50M	-0.50M	0.26M	1.06M	1.24M	2.00M	1.93M	2.25M	0.35M	0.86M	1.23M	1.10M
Operating items
Research & Development (Quarter)	5.64M	7.35M	6.78M	8.02M	7.03M	2.92M	3.59M	2.18M	3.38M	2.38M	2.04M	2.62M	2.58M	2.34M	3.47M	5.09M	3.14M	4.18M	2.35M	2.14M
Selling, General & Administrative (Quarter)	3.14M	3.56M	3.24M	2.99M	3.73M	3.14M	3.23M	1.62M	2.17M	2.52M	1.41M	1.38M	1.22M	1.14M	0.85M	1.03M	1.37M	0.95M	1.02M	0.85M
Other Operating Expenses (Quarter)																	0.45M
Operating Expenses (Quarter)	8.78M	10.91M	10.02M	11.01M	10.76M	6.06M	6.83M	3.80M	5.54M	4.90M	3.46M	3.99M	3.79M	3.48M	4.33M	6.11M	4.96M	5.12M	3.37M	2.99M
Operating Income (Quarter)	-8.78M	-10.91M	-10.02M	-9.76M	-9.79M	-5.27M	-5.83M	-3.04M	-4.31M	-4.13M	-3.20M	8.70M	-2.55M	-2.31M	-2.40M	5.01M	-4.61M	-4.26M	-2.14M	8.45M
EBIT (Quarter)	-8.78M	-10.91M	-10.02M	-9.76M	-9.79M	-5.27M	-5.83M	-3.04M	-4.31M	-4.13M	-3.20M	8.70M	-2.55M	-2.31M	-2.40M	5.01M	-4.61M	-4.26M	-2.14M	8.45M
Non-operating items
Non Operating Investment Income (Quarter)
Interest & Investment Income (Quarter)	0.00M	0.00M	791.00	969.00	0.00M	0.04M	0.10M	0.11M	0.08M	0.04M	0.22M	0.20M	0.16M	0.12M	0.09M	0.07M	0.16M	0.13M	0.14M	0.17M
Other Non Operating Income (Quarter)																		0.12M
Net income details
EBT (Quarter)	-8.78M	-10.91M	-10.02M	-9.76M	-9.79M	-5.23M	-5.73M	-2.93M	-4.22M	-4.10M	-2.98M	8.90M	-2.39M	-2.19M	-2.31M	5.09M	-4.45M	-4.13M	-2.00M	8.61M
Profit After Tax (Quarter)	-8.78M	-10.91M	-12.43M	-9.76M	-9.91M	-9.24M	-5.73M	-3.04M	-4.97M	2.52M	-2.98M	-2.74M	-2.39M	-2.19M	-2.31M	-3.84M	-4.45M	-4.02M	-2.00M	-1.70M
Income from Continuing Operations (Quarter)	-8.78M	-10.91M	-10.02M	-9.76M	-9.79M	-5.23M	-5.73M	-2.93M	-4.22M	-4.10M	-2.98M	8.90M	-2.39M	-2.19M	-2.31M	5.09M	-4.45M	-4.13M	-2.00M	8.61M
Consolidated Net Income (Quarter)	-8.78M	-10.91M	-10.02M	-9.76M	-9.79M	-4.01M	-1.19M	-0.81M	-0.74M	6.61M	-8.79M	8.73M	-2.39M	-2.19M	-2.31M	5.09M	-4.45M	-4.13M	-2.00M	8.61M
Income towards Parent Company (Quarter)	-8.78M	-10.91M	-10.02M	-9.76M	-9.79M	-4.01M	-1.19M	-0.81M	-0.74M	6.61M	-8.79M	8.73M	-2.39M	-2.19M	-2.31M	5.09M	-4.45M	-4.13M	-2.00M	8.61M
Net Income towards Common Stockholders (Quarter)	-8.78M	-10.91M	-10.02M	-9.76M	-9.79M	-4.01M	-1.19M	-0.81M	-0.74M	6.61M	-8.79M	8.73M	-2.39M	-2.19M	-2.31M	5.09M	-4.45M	-4.13M	-2.00M	8.61M
Additional items
EPS (Basic) (Quarter)	-0.16	-0.13	-0.15	-5.04	-1.19	-0.63	-0.83	-1.57	-0.48	0.29	-0.34	-0.30	-0.27	-0.25	-0.26	-0.42	-0.40	-0.29	-0.12	-0.04
EPS (Weighted Average and Diluted) (Quarter)	-0.16	-0.13	-0.15	-5.04	-1.19	-0.63	-0.69	0.76	-0.48	0.29	-0.34	-0.30	-0.27	-0.25	-0.26	-0.42	-0.40	-0.29	-0.12	-0.04
Shares Outstanding (Weighted Average) (Quarter)	56.47M	83.03M	74.29M	1.98M	8.31M	8.34M	8.34M	8.35M	8.72M	8.76M	8.83M	8.81M	8.90M	8.92M	8.91M	8.98M	11.11M	13.96M	13.96M	15.31M
Shares Outstanding (Diluted Average) (Quarter)	56.47M	69.82M	83.08M	7.65M	8.31M	8.34M	8.34M	8.35M	8.72M	8.80M	8.83M	8.81M	8.90M	8.91M	8.91M	8.98M	11.11M	13.96M	13.96M	15.31M
EBITDA (Quarter)	-8.78M	-10.91M	-10.02M	-9.76M	-9.79M	-5.27M	-5.83M	-3.04M	-4.31M	-4.13M	-3.20M	8.70M	-2.55M	-2.31M	-2.40M	5.01M	-4.61M	-4.26M	-2.14M	8.45M
Shares Outstanding (Quarter)	83.01M	83.08M	83.08M	8.31M	8.35M	8.36M	8.36M	8.41M	8.80M	8.80M	8.89M	8.89M	8.91M	8.92M	8.92M	10.71M	11.21M	11.31M	16.70M	16.70M

Research Tools

Marker Therapeutics Income Statement (2015-2025) | MRKR

Create an account

Sign In

Reset Password